NO156694C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.

Info

Publication number
NO156694C
NO156694C NO81812509A NO812509A NO156694C NO 156694 C NO156694 C NO 156694C NO 81812509 A NO81812509 A NO 81812509A NO 812509 A NO812509 A NO 812509A NO 156694 C NO156694 C NO 156694C
Authority
NO
Norway
Prior art keywords
propadienyl
steroids
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO81812509A
Other languages
English (en)
Norwegian (no)
Other versions
NO156694B (no
NO812509L (no
Inventor
Brian W Metcalf
J O Neal Johnston
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Priority to NO81812509A priority Critical patent/NO156694C/no
Publication of NO812509L publication Critical patent/NO812509L/no
Priority to NO86861695A priority patent/NO158380C/no
Publication of NO156694B publication Critical patent/NO156694B/no
Publication of NO156694C publication Critical patent/NO156694C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO81812509A 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider. NO156694C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO81812509A NO156694C (no) 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO86861695A NO158380C (no) 1980-06-27 1986-04-29 Nye 10-(1,2-propadienyl)steroider og antikonsepsjonsmidler inneholdende disse.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/163,453 US4289762A (en) 1980-06-27 1980-06-27 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
NO81812509A NO156694C (no) 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.

Publications (3)

Publication Number Publication Date
NO812509L NO812509L (no) 1983-01-24
NO156694B NO156694B (no) 1987-07-27
NO156694C true NO156694C (no) 1987-11-04

Family

ID=22590073

Family Applications (1)

Application Number Title Priority Date Filing Date
NO81812509A NO156694C (no) 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.

Country Status (21)

Country Link
US (1) US4289762A (fr)
JP (1) JPS5738798A (fr)
AT (1) AT377989B (fr)
AU (1) AU539215B2 (fr)
BE (1) BE889404A (fr)
CA (1) CA1173432A (fr)
CH (1) CH647532A5 (fr)
DE (1) DE3124719C2 (fr)
DK (1) DK163129C (fr)
ES (1) ES8400449A1 (fr)
FR (1) FR2485544A1 (fr)
GB (1) GB2078750B (fr)
IE (1) IE51352B1 (fr)
IL (1) IL63142A0 (fr)
IT (1) IT1171340B (fr)
NL (1) NL8103098A (fr)
NO (1) NO156694C (fr)
NZ (1) NZ197495A (fr)
PH (1) PH16690A (fr)
SE (1) SE448878B (fr)
ZA (1) ZA814219B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3362176D1 (en) * 1982-07-14 1986-03-27 Akzo Nv Novel 19-thio-androstane derivatives
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
EP0114033B1 (fr) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Azabicycloalcanes substitués, leur utilisation, préparations pharmaceutiques contenant ces composés et procédé pour la préparation de ces composés
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
US4634694A (en) * 1984-01-14 1987-01-06 Akzo N.V. Novel Δ4 - and Δ5 -androstene derivatives and pharmaceutical compositions containing these derivatives
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
WO1996024123A1 (fr) 1995-02-01 1996-08-08 Seiko Epson Corporation Affichage a cristaux liquides et ses procedes de commande et de verification
MXPA03009446A (es) * 2001-04-17 2004-05-24 Ares Trading Sa Inhibicion de aromatasa para mejorar reproduccion asistida.
DE10141937A1 (de) * 2001-08-28 2003-03-27 Alfred Schmidt Markierung der Aromatase
EP1854465A1 (fr) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Utilisation du 4,17 béta-dihydroxyandrost-4-ene-3-one pour traiter les cancers
EP2556082B1 (fr) 2010-04-08 2017-02-22 Emory University Androst-4-ène diones substituées
EP3666276A1 (fr) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Médicament contre la tumeur positive du récepteur d'oestrogene beta (erbeta)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102127A (en) * 1962-06-12 1963-08-27 Syntex Corp 19-methylene-androstane derivatives
FR1519387A (fr) * 1966-04-20 1968-03-29 Hoffmann La Roche Procédé pour la préparation de 19-alcényl-stéroïdes
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
CH606101A5 (fr) * 1975-01-30 1978-10-13 Ciba Geigy Ag

Also Published As

Publication number Publication date
GB2078750A (en) 1982-01-13
DE3124719C2 (de) 1994-03-03
IE811435L (en) 1981-12-27
DK163129B (da) 1992-01-20
IL63142A0 (en) 1981-09-13
NO156694B (no) 1987-07-27
ES503451A0 (es) 1983-11-01
IE51352B1 (en) 1986-12-10
JPH0121158B2 (fr) 1989-04-19
CH647532A5 (de) 1985-01-31
NL8103098A (nl) 1982-01-18
IT1171340B (it) 1987-06-10
NZ197495A (en) 1985-01-31
AU7236981A (en) 1982-01-07
AT377989B (de) 1985-05-28
PH16690A (en) 1984-01-06
CA1173432A (fr) 1984-08-28
IT8148781A0 (it) 1981-06-26
US4289762A (en) 1981-09-15
SE448878B (sv) 1987-03-23
GB2078750B (en) 1984-08-22
AU539215B2 (en) 1984-09-13
ATA285881A (de) 1984-10-15
ES8400449A1 (es) 1983-11-01
JPS5738798A (en) 1982-03-03
FR2485544A1 (fr) 1981-12-31
NO812509L (no) 1983-01-24
DE3124719A1 (de) 1982-03-18
ZA814219B (en) 1982-07-28
FR2485544B1 (fr) 1983-12-16
BE889404A (fr) 1981-12-28
SE8103988L (sv) 1981-12-28
DK284481A (da) 1981-12-28
DK163129C (da) 1992-06-09

Similar Documents

Publication Publication Date Title
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO156752C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO152091C (no) Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-difenylthiofener
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.